You have 9 free searches left this month | for more free features.

Dyspnea

Showing 26 - 50 of 8,916

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Treatment of Dyspnea in Do-not-intubate Patients

Active, not recruiting
  • Acute Respiratory Failure
  • +2 more
  • NIV
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 2, 2023

Multidimensional Assessment of Dyspnea in Asthma

Terminated
  • Asthma
  • Questionnaire
  • Dunkerque, France
  • +4 more
Jan 23, 2023

Shortness of Breath Trial in Lahore (INCENTIVE SPIROMETRY, Active cycle of breathing)

Recruiting
  • Shortness of Breath
  • INCENTIVE SPIROMETRY
  • Active cycle of breathing
  • Lahore, Punjab, Pakistan
    Iettefaq hospital
Dec 9, 2022

Exertional Dyspnea and Exercise Intolerance in COVID-19

Active, not recruiting
  • Covid19
  • Dyspnea
  • No Intervention
  • Edmonton, Alberta, Canada
    Clinical Physiology Laboratory
Dec 5, 2022

Asthma Trial in Faisalabad (Flutter device, positive expiratory pressure mask)

Recruiting
  • Asthma
  • Flutter device
  • positive expiratory pressure mask
  • Faisalābad, Punjab, Pakistan
    Allied hospital
Jan 23, 2023

Tachycardia, Dyspnea, COVID-19 Trial in Hackensack (Metoprolol Succinate)

Recruiting
  • Tachycardia
  • +2 more
  • Metoprolol Succinate
  • Hackensack, New Jersey
    Hackensack Univeristy Medical Center
Dec 13, 2022

Multidimensional Characterization of Dyspnea in Children

Not yet recruiting
  • Study Focus on Patients Aged Between 6-17 Years, Experiencing Dyspnea and Presenting With Acute Respiratory Insufficiency or Chronic Respiratory Insufficiency
  • Multidimentional observation scale (MDP)
  • (no location specified)
Aug 11, 2022

Open Trial of Biofeedback for Respiratory Symptoms

Not yet recruiting
  • Shortness of Breath/Dyspnea
    • (no location specified)
    Jul 31, 2023

    Dyspnea Trial in Paris (Auditive stimulation, Sensitive stimulation, Auditory control)

    Completed
    • Dyspnea
    • Auditive stimulation
    • +3 more
    • Paris, France
      Service de Pneumologie et Réanimation Médicale, Groupe Hospitali
    Sep 1, 2022

    Bronchiolectasis Trial in Lahore (PEP (Positive Expiratory Pressure), IS (Incentive spirometry))

    Completed
    • Bronchiolectasis
    • PEP (Positive Expiratory Pressure)
    • IS (Incentive spirometry)
    • Lahore, Punjab, Pakistan
      Mayo Hospital Lahore
    Jan 31, 2023

    COPD, Emphysema, Lung Diseases Trial in Scottsdale, Jacksonville, Rochester (Coaching and Weight Loss for patients with dyspnea,

    Completed
    • COPD
    • +2 more
    • Coaching and Weight Loss for patients with dyspnea
    • Active Control
    • Scottsdale, Arizona
    • +2 more
    Oct 31, 2022

    Dyspnea, Quality of Life Trial (Bariatric surgery, Medical weight loss)

    Not yet recruiting
    • Dyspnea
    • Quality of Life
    • Bariatric surgery
    • Medical weight loss
    • (no location specified)
    Apr 18, 2023

    Dyspnea Trial in Volterra (TENS and pulmonary rehabilitation)

    Suspended
    • Dyspnea
    • TENS and pulmonary rehabilitation
    • Volterra, Pisa, Italy
      Santa Maria Maddalena Hospital
    Oct 20, 2022

    Acute Respiratory Failure Trial in Paris (Chlorhydrate de morphine, NaCl 0,9%,)

    Completed
    • Acute Respiratory Failure
    • Chlorhydrate de morphine
    • NaCl 0,9%,
    • Paris, France
      Groupe Hospitalier Pitié Salpetriere
    Oct 24, 2022

    Clinician Assessment of Patient Dyspnea

    Recruiting
    • Dyspnea
      • Chicago, Illinois
        Rush University Medical Center
      Apr 25, 2022

      Dyspnea Trial in Newark (Socialization phase, Speech breathing intervention)

      Completed
      • Dyspnea
      • Socialization phase
      • Speech breathing intervention
      • Newark, Delaware
        University of Delaware
      Jun 24, 2022

      Decompensated Heart Failure Trial in Porto Alegre (Immersive Virtual Reality glasses, early mobilization protocol)

      Recruiting
      • Decompensated Heart Failure
      • Immersive Virtual Reality glasses
      • early mobilization protocol
      • Porto Alegre, RS, Brazil
        Hospital de Clinicas de Porto Alegre
      Dec 1, 2022

      Dyspnea Trial in Denmark (Point-of-care ultrasound-driven diagnostic pathway)

      Recruiting
      • Dyspnea
      • Point-of-care ultrasound-driven diagnostic pathway
      • Aarhus, Central Denmark Region, Denmark
      • +6 more
      Jan 25, 2023

      COPD Trial in Edmonton (Sildenafil Citrate, Placebo)

      Recruiting
      • Chronic Obstructive Pulmonary Disease
      • Sildenafil Citrate
      • Placebo
      • Edmonton, Alberta, Canada
        Clinical Physiology Laboratory
      Dec 5, 2022

      Dyspnea, Pulmonary Embolism Trial in Kingston (Nitric Oxide, Placebo)

      Recruiting
      • Dyspnea
      • Pulmonary Embolism
      • Nitric Oxide
      • Placebo
      • Kingston, Ontario, Canada
        Respiratory Investigation Unit, Kingston General Hospital
      Sep 8, 2022

      Pulmonary Disease, Chronic Obstructive, Health-Related Quality Of Life, Dyspnea Trial in Ordu, Malatya (Exercise)

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • +2 more
      • Exercise
      • Ordu, Altınordu, Turkey
      • +1 more
      May 26, 2023

      Dyspnea, Malignant Tumor Trial in Houston (Dexamethasone, Placebo, Questionnaire Administration)

      Active, not recruiting
      • Dyspnea
      • Malignant Neoplasm
      • Houston, Texas
      • +2 more
      Nov 29, 2022

      Autonomic Monitoring in Neurocardiogenic Syncope

      Enrolling by invitation
      • Syncope
      • +2 more
        • Cincinnati, Ohio
          Cincinnati Children's Hospital Medical Center
        Jun 7, 2023

        Asthma in Children, Dyspnea; Asthmatic, Obesity, Childhood Trial in Columbus (Control, Albuterol, Ipratropium Bromide)

        Not yet recruiting
        • Asthma in Children
        • +2 more
        • Control
        • +2 more
        • Columbus, Ohio
          The Ohio State University
        Jul 8, 2022

        SARS-CoV 2, COVID, ARDS Trial (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo)

        Withdrawn
        • SARS-CoV 2
        • +5 more
        • ZYESAMI™ (aviptadil acetate)
        • +2 more
        • (no location specified)
        Feb 2, 2023